Financial Performance - In 2024, the company achieved a revenue of CNY 2.121 billion and a net profit of CNY 165 million, supported by strong sales from the Nanjing Binjiang Yayuan and Rongjin Ruifu projects [3][4] - The company's asset-liability ratio at the end of the reporting period was 32.64%, with a net asset-liability ratio of 29.17%, marking a historical low for the company [4] Business Strategy - The company adheres to a "low debt, high return" operational strategy, focusing on stable real estate development and a regulated medical beauty business as growth engines [3][4] - The medical beauty segment has established a "Six Cities, Six Hospitals" strategic layout, with plans to expand in economically strong regions like the Yangtze River Delta [4] Industry Outlook - The real estate industry is stabilizing after a period of adjustment, with a focus on product quality and customer satisfaction as key competitive advantages [5][6] - The market is expected to undergo further consolidation, leading to a higher concentration of industry players and a shift towards high-quality development [5][6] Shareholder Returns - The profit distribution plan for 2024 proposes a cash dividend of CNY 0.40 per 10 shares, totaling CNY 121 million, which represents 73.49% of the net profit attributable to shareholders [6] - Over the past three years, the company has distributed a total of CNY 753 million in cash dividends, emphasizing its commitment to shareholder returns [6]